Farletuzumab in epithelial ovarian carcinoma

Author： Spannuth Whitney A   Sood Anil K   Coleman Robert L  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.3, 2010-03, pp. : 431-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines

By Jang Eun-Ra   Kim Yun   Myung Soon   Kim Wonyong   Lee Chung  

Molecular and Cellular Biochemistry, Vol. 353, Iss. 1-2, 2011-07 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Calcium-Mediated Telomerase Activity in Ovarian Epithelial Cells

By Alfonso-de Matte M.Y.   Moses-Soto H.   Kruk P.A.  

Archives of Biochemistry and Biophysics, Vol. 399, Iss. 2, 2002-03 ,pp. : 239-244

Elsevier

Access to resources Recommend Favorite

Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

By  

Current Enzyme Inhibition, Vol. 1, Iss. 2, 2005-06 ,pp. : 157-170

Bentham Science Publishers

Access to resources Recommend Favorite

A repertoire of biomarkers helps in detection and assessment of therapeutic response in epithelial ovarian cancer

By Choudhuri Sharmistha   Sharma Chandresh   Banerjee Ayan   Kumar Sunesh   Kumar Lalit   Singh Neeta  

Molecular and Cellular Biochemistry, Vol. 386, Iss. 1-2, 2014-01 ,pp. : 259-269

Springer Publishing Company

Access to resources Recommend Favorite

Effects of RI Overexpression on Cisplatin Sensitivity in Human Ovarian Carcinoma Cells

By Cvijic M.E.   Chin K-V.  

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 3, 1998-08 ,pp. : 723-727

Elsevier

Access to resources Recommend Favorite